These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15368468

  • 1. Inhibitory effect of IL-6-induced neuroendocrine cells on prostate cancer cell proliferation.
    Wang Q, Horiatis D, Pinski J.
    Prostate; 2004 Nov 01; 61(3):253-9. PubMed ID: 15368468
    [Abstract] [Full Text] [Related]

  • 2. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
    Yuan TC, Veeramani S, Lin MF.
    Endocr Relat Cancer; 2007 Sep 01; 14(3):531-47. PubMed ID: 17914087
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO, Chun JY, Nadiminty N, Lou W, Gao AC.
    Prostate; 2007 May 15; 67(7):764-73. PubMed ID: 17373716
    [Abstract] [Full Text] [Related]

  • 4. Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells.
    Untergasser G, Plas E, Pfister G, Heinrich E, Berger P.
    Prostate; 2005 Sep 01; 64(4):419-29. PubMed ID: 15800938
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation.
    Wang Q, Horiatis D, Pinski J.
    Int J Cancer; 2004 Sep 10; 111(4):508-13. PubMed ID: 15239127
    [Abstract] [Full Text] [Related]

  • 6. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K, Mizokami A, Li YQ, Narimoto K, Sugimoto K, Kadono Y, Kitagawa Y, Konaka H, Koh E, Keller ET, Namiki M.
    Prostate; 2009 Aug 01; 69(11):1222-34. PubMed ID: 19434660
    [Abstract] [Full Text] [Related]

  • 7. [The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells].
    Song Y, Wu G, Xin DQ, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2004 Dec 07; 42(23):1453-6. PubMed ID: 15733464
    [Abstract] [Full Text] [Related]

  • 8. Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2.
    Diaz M, Abdul M, Hoosein N.
    Prostate Suppl; 1998 Dec 07; 8():32-6. PubMed ID: 9690661
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Constitutive activation of gp130 leads to neuroendocrine differentiation in vitro and in vivo.
    Palmer J, Ernst M, Hammacher A, Hertzog PJ.
    Prostate; 2005 Feb 15; 62(3):282-9. PubMed ID: 15389784
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines.
    Copeland RL, Das JR, Bakare O, Enwerem NM, Berhe S, Hillaire K, White D, Beyene D, Kassim OO, Kanaan YM.
    Anticancer Res; 2007 Feb 15; 27(3B):1537-46. PubMed ID: 17595773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
    Tawadros T, Alonso F, Jichlinski P, Clarke N, Calandra T, Haefliger JA, Roger T.
    Endocr Relat Cancer; 2013 Feb 15; 20(1):137-49. PubMed ID: 23207293
    [Abstract] [Full Text] [Related]

  • 17. Neuroendocrine differentiation in human prostatic tumor models.
    Noordzij MA, van Weerden WM, de Ridder CM, van der Kwast TH, Schröder FH, van Steenbrugge GJ.
    Am J Pathol; 1996 Sep 15; 149(3):859-71. PubMed ID: 8780390
    [Abstract] [Full Text] [Related]

  • 18. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF.
    Endocr Relat Cancer; 2006 Mar 15; 13(1):151-67. PubMed ID: 16601285
    [Abstract] [Full Text] [Related]

  • 19. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 20. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells.
    Yang X, Chen MW, Terry S, Vacherot F, Chopin DK, Bemis DL, Kitajewski J, Benson MC, Guo Y, Buttyan R.
    Cancer Res; 2005 Jun 15; 65(12):5263-71. PubMed ID: 15958572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.